Showing results (71-80 of 1,757) with videos related to
Sort By:
Pageof 176
Progress in Cardiovascular Diseases|May 15, 2002
The importance of effect mechanism in the design and interpretation of clinical trials: the role of magnesium in acute myocardial infarctionKent L Woods, Keith AbramsProgress in Cardiovascular Diseases|May 15, 2002
Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular diseaseJohn G F ClelandProgress in Cardiovascular Diseases|June 22, 2002
Dyslipidemia and the vulnerable plaqueJohn A Farmer, Antonio M GottoProgress in Cardiovascular Diseases|June 22, 2002
Pharmacogenomics in cardiovascular diseasesDebabrata Mukherjee, Eric J TopolProgress in Cardiovascular Diseases|May 25, 2002
Pathophysiology of plaque instability: insights at the genomic levelNeuza Lopes, Sanjay S Vasudevan, Rene J Alvarez, et al.Progress in Cardiovascular Diseases|August 16, 2003
Implications of cigarette smoking for the management of patients with acute coronary syndromesLouise Metz, David D WatersProgress in Cardiovascular Diseases|January 1, 1976
Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular functionJ RossProgress in Cardiovascular Diseases|January 28, 2019
Implementing behaviour change theory and techniques to increase physical activity and prevent functional decline among adults aged 61-70: The PreventIT projectElisabeth Boulton, Helen Hawley-Hague, David P French, et al.Progress in Cardiovascular Diseases|November 11, 2019
Tricuspid regurgitation is a public health crisisMaurice Enriquez-Sarano, David Messika-Zeitoun, Yan Topilsky, et al.Progress in Cardiovascular Diseases|November 13, 2019
Impact of fitness and changes in fitness on lipids and survivalCarl J Lavie, Sergey Kachur, Xuemei SuiPageof 176